Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RTBDN antisense RNA 1 (RTBDN-AS1)
- Target
- RTBDN-AS1
- Molecular classification
- Long non-coding RNA (lncRNA)
01
Overview
RTBDN antisense RNA 1 (RTBDN-AS1) is a human long non-coding RNA (lncRNA) gene located at HGNC: 58174, NCBI Gene: 105372281, and Ensembl: ENSG00000267424. It is classified under the lncRNA molecular class and is transcribed as an RNA molecule that does not code for a protein. Its expression, function, and potential disease associations have not been well characterized in the public literature or major genomic databases. To date, there is no evidence that RTBDN-AS1 is a druggable target, nor are there documented biological functions, disease involvements, drug interactions, or clinical biomarker roles. RTBDN-AS1 should not be confused with the protein-coding gene RTBDN (Retbindin), which has neuroprotective roles in the retina and is implicated in retinal metabolism and degeneration, but they are distinct entities: RTBDN-AS1 refers to an antisense lncRNA.
- Other names
- CTD-2265O21.3RTBDN-AS1
02
Mechanism of action
None known.
03
Biological functions
Unknown
04
Disease associations
Unknown
Beyond the preview
Go deeper on RTBDN antisense RNA 1 (RTBDN-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RTBDN antisense RNA 1 (RTBDN-AS1).